These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 386740

  • 1. The role of thromboxane A2 in endotoxin-induced aggregation of guinea-pig platelets in vitro.
    Bult H, Herman AG.
    Agents Actions Suppl; 1979; (4):147-55. PubMed ID: 386740
    [Abstract] [Full Text] [Related]

  • 2. Thromboxane A2 biosynthesis during endotoxin-induced aggregation of platelets from normal and sensitized guinea-pigs.
    Bult H, Herman AG.
    Agents Actions; 1979 Dec; 9(5-6):560-5. PubMed ID: 397765
    [Abstract] [Full Text] [Related]

  • 3. Arachidonic acid-induced platelet aggregation and thromboxane A2 generation in patients with coronary heart disease.
    Szczeklik A, Gryglewski RJ, Musiał J, Grodzínska L, Serwónska M, Wójcik-Switek L, Marcinkiewicz E.
    Acta Biol Med Ger; 1978 Dec; 37(5-6):741-2. PubMed ID: 742286
    [Abstract] [Full Text] [Related]

  • 4. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
    Block HU, Heinroth I, Giessler C, Pönicke K, Mentz P, Zehl U, Rettkowski W, Dunemann A, Förster W.
    Biomed Biochim Acta; 1983 Dec; 42(2-3):283-99. PubMed ID: 6411078
    [Abstract] [Full Text] [Related]

  • 5. Leukocytes, platelets, and thromboxane A2 in endotoxin-induced lung injury.
    Smith ME, Gunther R, Gee M, Flynn J, Demling RH.
    Surgery; 1981 Jul; 90(1):102-7. PubMed ID: 7017990
    [Abstract] [Full Text] [Related]

  • 6. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I, Block HU, Mest HJ.
    Biomed Biochim Acta; 1984 Jul; 43(8-9):S389-92. PubMed ID: 6440555
    [Abstract] [Full Text] [Related]

  • 7. Thromboxane biosynthesis in platelets of diabetic and coronary artery diseased patients.
    Butkus A, Shirey EK, Schumacher OP.
    Artery; 1982 Jul; 11(3):238-51. PubMed ID: 7184495
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aggregation and inhibition of rat platelets, and the formation of endoperoxide metabolites.
    Hwang DH.
    Prostaglandins Med; 1980 Sep; 5(3):163-73. PubMed ID: 7413850
    [Abstract] [Full Text] [Related]

  • 10. Increased platelet thromboxane synthesis in diabetes mellitus.
    Halushka PV, Rogers RC, Loadholt CB, Colwell JA.
    J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
    [Abstract] [Full Text] [Related]

  • 11. Effects of thromboxane antagonist EP 045 on platelet aggregation.
    Jones RL, Wilson NH, Armstrong RA, Peesapati V, Smith GM.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Jan; 11():345-50. PubMed ID: 6303074
    [No Abstract] [Full Text] [Related]

  • 12. Endotoxin-induced platelet activation in human whole blood in vitro.
    Csako G, Suba EA, Elin RJ.
    Thromb Haemost; 1988 Jun 16; 59(3):378-82. PubMed ID: 3055412
    [Abstract] [Full Text] [Related]

  • 13. Platelet shape change in whole blood: differential effects of endotoxin.
    Nystrom ML, Barradas MA, Jeremy JY, Mikhailidis DP.
    Thromb Haemost; 1994 May 16; 71(5):646-50. PubMed ID: 8091394
    [Abstract] [Full Text] [Related]

  • 14. Endotoxin receptor site. II. Specificity of endotoxin receptor of platelets and sensitivity to endotoxin in vivo.
    Washida S.
    Acta Med Okayama; 1978 Jul 16; 32(3):217-23. PubMed ID: 151487
    [Abstract] [Full Text] [Related]

  • 15. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
    Bureau MF, De Clerck F, Lefort J, Arreto CD, Vargaftig BB.
    J Pharmacol Exp Ther; 1992 Feb 16; 260(2):832-40. PubMed ID: 1738127
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
    Block HU, Förster W, Heinroth I.
    Arzneimittelforschung; 1982 Feb 16; 32(3):189-94. PubMed ID: 6896278
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.